New Vaccine Created by Mizzou Researchers Protects Cattle From Deadly Tick-borne Disease
Published 8/29/2024MizzouForward researcher Roman Ganta has created the first effective vaccine proven to protect cattle from bovine anaplasmosis, benefiting both cattle health and the agricultural economy.
CVM Researchers Shed Light on Approaches to Improve Veterinary Student Wellbeing
Published 8/28/2024Kerry Karaffa, PhD, LP, Tamara Hancock, DVM, MS, DACVP, and Tiffany Sanford-Martens, PhD, LP, recently published their research titled, “Perfectionistic Cognitions, Self-Compassion, and Psychological Distress Among Veterinary Students” in the Journal of College Student Mental Health.
Sniffing up Scientific Discovery: Five Ways Mizzou Research Benefits Dogs
Published 8/23/2024To celebrate National Dog Day, learn how researchers at Mizzou help both dogs and their human companions.
Small But Mighty: Microparticles From The Placenta May Offer Major Clues on the In Utero Development of Neurobehavioral Disorders
Published 11/29/2023For 30 years, Cheryl Rosenfeld has studied how biological information gets transferred from mothers to babies during pregnancy. The research is personal for Rosenfeld, whose niece, Sara, was exposed to sedative drugs in utero.
Task Force Elevates Collaboration Between University of Missouri and India
Published 11/16/2023A new team of researchers spanning medicine, engineering and veterinary science is working with researchers in India to expand opportunities for collaboration and innovation.
Detecting disease
Published 11/3/2023The Animal Infection and Monitoring Services core supports studies on a wide variety of bacterial and viral diseases.
Trailblazing treatments
Published 11/3/2023Teresa Lever is developing tools to objectively diagnose and treat swallowing impairments associated with neurological diseases, cancer, genetic disorders and aging.
Ongoing Vaccine Projects Address 100-year-old Disease and Others in Fight Against Tick-borne Diseases
Published 10/11/2023Ongoing vaccine projects address 100-year-old disease and others in fight against tick-borne diseases.
Chris Lorson on fast track for spinal muscular atrophy drug
Published 10/9/2023Curators’ Distinguished Professor Chris Lorson is forging a new path at the University of Missouri for drug development and clinical trials using a $4.3 million National Institutes of Health (NIH) Blueprint for Neuroscience Research grant.
$12 Million Grant Will Boost Workforce Development at MU’s Laboratory for Infectious Disease Research
Published 8/21/2023NIH-funded grant will provide additional trainings and support to existing University of Missouri employees, as well as recruit new employees.